Key result
Novel de novo HECW2 variant identified as cause of severe fetal hypertrophic cardiomyopathy.
Why the study?
HECW2 pathogenic variants have been linked to neurodevelopmental disorders, but their role in fetal cardiac abnormalities and cardiomyopathy remains unclear.
Case Report (n=1)
This case expands the phenotypic spectrum of HECW2 mutations to include severe prenatal hypertrophic cardiomyopathy and hydrops fetalis.
May warrant HECW2 testing in unexplained fetal HCM with hydrops; extends phenotypic spectrum but leaves open broader adoption.
Summary What's already known about this topic? What does this study add?
No takes yet. Share an insight, caveat, or question.
Nimchenko et al. (2026) conducted a case report in Fetal cardiac abnormalities (hypertrophic cardiomyopathy, hydrops fetalis) (n=1). HECW2 gene pathogenic variant (c.4511C > T, p.(Ser1504Phe)) was evaluated on Identification of genetic etiology. A novel de novo HECW2 pathogenic variant (c.4511C > T) was identified as the cause of severe fetal hypertrophic cardiomyopathy and hydrops fetalis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: